Adenocarcinoma of the uterine cervix:: the presence of human papillomavirus and the method of detection

被引:29
作者
Andersson, S [1 ]
Larson, B
Hjerpe, A
Silfverswärd, C
Sällström, J
Wilander, E
Rylander, E
机构
[1] Huddinge Univ Hosp, Karolinska Inst, Inst Clin Sci, Div Obstet & Gynecol, S-14186 Stockholm, Sweden
[2] Karolinska Hosp, Dept Women & Child Hlth, Div Obstet & Gynecol, S-10401 Stockholm, Sweden
[3] Huddinge Univ Hosp, Karolinska Inst, Dept Pathol & Cytol, Stockholm, Sweden
[4] Karolinska Hosp, Dept Pathol, S-10401 Stockholm, Sweden
[5] Univ Uppsala Hosp, Dept Genet & Pathol, Sect Clin Cytol, Uppsala, Sweden
[6] Danderyd Hosp, Karolinska Inst, Div Obstet & Gynecol, Stockholm, Sweden
关键词
adenocarcinoma; cervix; human papillomavirus (HPV); cervical screening; oral contraceptives; smoking;
D O I
10.1034/j.1600-0412.2003.00263.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Effective screening programs have contributed to a decrease in the incidence of cervical squamous cell carcinomas but have had a limited sensitivity in the detection of adenocarcinoma precursor lesions. The aim of our study was to analyze cervical adenocarcinoma in greater detail: symptoms preceding the detection, the method of detection and the prevalence of human papillomavirus (HPV) with respect to age at diagnosis. Material and methods. Clinical data were abstracted from the medical records of 82 women with pure invasive cervical adenocarcinomas. As diagnostic tools we used polymerase chain reaction (PCR)-based single-strand conformation polymorphism (SSCP) and/or direct DNA sequencing for HPV detection. Results. Age at diagnosis predicting factors were HPV status, positive lymph nodes, histology and stage. HPV-negativity, lymph node metastases, advanced stage and poor differentiation were all associated with a high diagnostic age. In the multivariate analysis only HPV status was shown to have an independent impact on age at diagnosis, while stage showed only borderline significance. Twenty-three percent of the cancers were detected by screening and the remaining were due to different symptoms. Among the women considered, 93% had a normal Papanicolaou (Pap) smear 3 years before diagnosis and 60% within 1 year. There was no significant correlation between smoking, oral contraceptives and HPV-positivity. Conclusions. The absence of HPV was significantly associated with a high age at diagnosis. Pap screening had a limited effect in detecting adenocarcinoma at an early stage.
引用
收藏
页码:960 / 965
页数:6
相关论文
共 42 条
[11]   Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women [J].
Forslund, O ;
Antonsson, A ;
Edlund, K ;
van den Brule, AJC ;
Hansson, BG ;
Meijer, CJLM ;
Ryd, W ;
Strand, A ;
Wadell, G ;
Dillner, J ;
Johansson, B .
JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) :535-541
[12]   Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire [J].
Herbert, A ;
Singh, N ;
Smith, JAE .
CYTOPATHOLOGY, 2001, 12 (01) :26-36
[13]   Risk factors for rapid-onset cervical cancer [J].
Hildesheim, A ;
Hadjimichael, O ;
Schwartz, PE ;
Wheeler, CM ;
Barnes, W ;
Lowell, DM ;
Willett, J ;
Schiffman, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (03) :571-577
[14]   ELEVATED NICOTINE LEVELS IN CERVICAL LAVAGES FROM PASSIVE SMOKERS [J].
JONES, CJ ;
SCHIFFMAN, MH ;
KURMAN, R ;
JACOB, P ;
BENOWITZ, NL .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1991, 81 (03) :378-379
[15]  
Krane JF, 2001, CANCER CYTOPATHOL, V93, P8, DOI 10.1002/1097-0142(20010225)93:1<8::AID-CNCR9001>3.3.CO
[16]  
2-B
[17]  
Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079
[18]   Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction [J].
Lee, MF ;
Chang, MC ;
Wu, CH .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 63 (03) :265-270
[19]   TYPING OF HUMAN PAPILLOMAVIRUSES BY POLYMERASE CHAIN-REACTION AMPLIFICATION WITH L1 CONSENSUS PRIMERS AND RFLP ANALYSIS [J].
LUNGU, O ;
WRIGHT, TC ;
SILVERSTEIN, S .
MOLECULAR AND CELLULAR PROBES, 1992, 6 (02) :145-152
[20]   PRESENCE AND PERSISTENCE OF HPV INFECTION AND P53 MUTATION IN CANCER OF THE CERVIX UTERI AND THE VULVA [J].
MILDELANGOSCH, K ;
ALBRECHT, K ;
JORAM, S ;
SCHLECHTE, H ;
GIESSING, M ;
LONING, T .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (05) :639-645